85 related articles for article (PubMed ID: 38571939)
1. Neutralizing antibody and CD8
Underwood AP; Sølund C; Jacobsen K; Binderup A; Fernandez-Antunez C; Mikkelsen LS; Inekci D; Villadsen SL; Castruita JAS; Pinholt M; Fahnøe U; Ramirez S; Brix L; Weis N; Bukh J
Front Immunol; 2024; 15():1353353. PubMed ID: 38571939
[TBL] [Abstract][Full Text] [Related]
2. Neutralizing antibody responses and cellular responses against SARS-CoV-2 Omicron subvariants after mRNA SARS-CoV-2 vaccination in kidney transplant recipients.
Kawashiro K; Suzuki R; Nogimori T; Tsujino S; Iwahara N; Hirose T; Okada K; Yamamoto T; Fukuhara T; Hotta K; Shinohara N
Sci Rep; 2024 May; 14(1):12176. PubMed ID: 38806644
[TBL] [Abstract][Full Text] [Related]
3. Functional antibody responses targeting the Spike protein of SARS-CoV-2 Omicron XBB.1.5 in elderly nursing home residents following Wuhan-Hu-1-based mRNA booster vaccination.
Sánchez-Simarro Á; Fernández-Soto D; Grau B; Albert E; Giménez E; Avilés-Alía AI; Gozalbo-Rovira R; Rusu L; Olea B; Geller R; Reyburn HT; Navarro D
Sci Rep; 2024 May; 14(1):11896. PubMed ID: 38789475
[TBL] [Abstract][Full Text] [Related]
4. Cellular mechanisms associated with sub-optimal immune responses to SARS-CoV-2 bivalent booster vaccination in patients with Multiple Myeloma.
Aleman A; van Kesteren M; Zajdman AK; Srivastava K; Cognigni C; Mischka J; Chen LY; Upadhyaya B; Serebryakova K; Nardulli JR; Lyttle N; Kappes K; Jackson H; Gleason CR; Oostenink A; Cai GY; Van Oekelen O; ; van Bakel H; Sordillo EM; Cordon-Cardo C; Merad M; Jagannath S; Wajnberg A; Simon V; Parekh S
EBioMedicine; 2023 Dec; 98():104886. PubMed ID: 37995467
[TBL] [Abstract][Full Text] [Related]
5. Antibody responses in blood and saliva post COVID-19 bivalent booster do not reveal an Omicron BA.4/BA.5- specific response.
Baker R; Lawlor R; Smith M; Price J; Eaton A; Lover A; Alfandari D; Reinhart P; Arcaro KF; Osborne BA
Front Immunol; 2024; 15():1401209. PubMed ID: 38812500
[TBL] [Abstract][Full Text] [Related]
6. Bivalent Coronavirus Disease 2019 Vaccine Antibody Responses to Omicron Variants Suggest That Responses to Divergent Variants Would Be Improved With Matched Vaccine Antigens.
Wang W; Goguet E; Paz S; Vassell R; Pollett S; Mitre E; Weiss CD
J Infect Dis; 2023 Aug; 228(4):439-443. PubMed ID: 37279924
[TBL] [Abstract][Full Text] [Related]
7. Ad5-nCoV Vaccination Could Induce HLA-E Restricted CD8
Wang Y; Yang L; Tang K; Zhang Y; Zhang C; Zhang Y; Jin B; Zhang Y; Zhuang R; Ma Y
Viruses; 2023 Dec; 16(1):. PubMed ID: 38257752
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of the BA.1 and BA.4/BA.5 Severe Acute Respiratory Syndrome Coronavirus 2 Bivalent Boosts: Preliminary Results From the COVAIL Randomized Clinical Trial.
Branche AR; Rouphael NG; Losada C; Baden LR; Anderson EJ; Luetkemeyer AF; Diemert DJ; Winokur PL; Presti RM; Kottkamp AC; Falsey AR; Frey SE; Rupp R; Bäcker M; Novak RM; Walter EB; Jackson LA; Little SJ; Immergluck LC; Mahgoub SM; Whitaker JA; Babu TM; Goepfert PA; Fusco DN; Atmar RL; Posavad CM; Netzl A; Smith DJ; Telu K; Mu J; Makowski M; Makhene MK; Crandon S; Montefiori DC; Roberts PC; Beigel JH
Clin Infect Dis; 2023 Aug; 77(4):560-564. PubMed ID: 37036397
[TBL] [Abstract][Full Text] [Related]
9. The breadth of the neutralizing antibody response to original SARS-CoV-2 infection is linked to the presence of Long COVID symptoms.
Buck AM; Deitchman AN; Takahashi S; Lu S; Goldberg SA; Bodansky A; Kung A; Hoh R; Williams MC; Kerbleski M; Maison DP; Deveau TM; Munter SE; Lombardo J; Wrin T; Petropoulos CJ; Durstenfeld MS; Hsue PY; Kelly JD; Greenhouse B; Martin JN; Deeks SG; Peluso MJ; Henrich TJ
J Med Virol; 2023 Nov; 95(11):e29216. PubMed ID: 37988251
[TBL] [Abstract][Full Text] [Related]
10. Durability of immunity and clinical protection in nursing home residents following bivalent SARS-CoV-2 vaccination.
Gravenstein S; DeVone F; Oyebanji OA; Abul Y; Cao Y; Chan PA; Halladay CW; McConeghy KW; Nugent C; Bosch J; King CL; Wilson BM; Balazs AB; White EM; Canaday DH
medRxiv; 2023 Apr; ():. PubMed ID: 37163130
[TBL] [Abstract][Full Text] [Related]
11. Repeated Omicron infection dampens immune imprinting from previous vaccination and induces broad neutralizing antibodies against Omicron sub-variants.
Gong X; Peng L; Wang F; Liu J; Tang Y; Peng Y; Niu S; Yin J; Guo L; Lu H; Liu Y; Yang Y
J Infect; 2024 Jun; ():106208. PubMed ID: 38908522
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 vaccination and booster induced authentic-virus neutralizing antibody response is superior to SARS-CoV-2 natural infection induced response.
Ching LL; Tseng AC; Nakano E; Salomon RC; Wang WK; Shikuma C; Nerurkar VR
J Clin Virol; 2022 Jul; 152():105185. PubMed ID: 35605371
[No Abstract] [Full Text] [Related]
13. T cell reactivity to the SARS-CoV-2 Omicron variant is preserved in most but not all individuals.
Naranbhai V; Nathan A; Kaseke C; Berrios C; Khatri A; Choi S; Getz MA; Tano-Menka R; Ofoman O; Gayton A; Senjobe F; Zhao Z; St Denis KJ; Lam EC; Carrington M; Garcia-Beltran WF; Balazs AB; Walker BD; Iafrate AJ; Gaiha GD
Cell; 2022 Mar; 185(6):1041-1051.e6. PubMed ID: 35202566
[TBL] [Abstract][Full Text] [Related]
14. Durability of immunity and clinical protection in nursing home residents following bivalent SARS-CoV-2 vaccination.
Gravenstein S; DeVone F; Oyebanji OA; Abul Y; Cao Y; Chan PA; Halladay CW; Rudolph JL; Nugent C; Bosch J; King CL; Wilson BM; Balazs AB; White EM; Canaday DH; McConeghy KW
EBioMedicine; 2024 Jun; 105():105180. PubMed ID: 38861869
[TBL] [Abstract][Full Text] [Related]
15. Variant-specific antibody response following repeated SARS-CoV-2 vaccination and infection.
Jiang XL; Song XD; Shi C; Yang GJ; Wang XJ; Zhang YW; Wu J; Zhao LX; Zhang MZ; Wang MM; Chen RR; He XJ; Dai EH; Gao HX; Shen Y; Dong G; Wang YL; Ma MJ
Cell Rep; 2024 Jun; 43(7):114387. PubMed ID: 38896777
[TBL] [Abstract][Full Text] [Related]
16. Antibody and T-cell response to bivalent booster SARS-CoV-2 vaccines in people with compromised immune function (COVERALL-3).
Amstutz A; Chammartin F; Audigé A; Eichenberger AL; Braun DL; Amico P; Stoeckle MP; Hasse B; Papadimitriou-Olivgeris M; Manuel O; Bongard C; Schuurmans MM; Hage R; Damm D; Tamm M; Mueller NJ; Rauch A; Günthard HF; Koller MT; Schönenberger CM; Griessbach A; Labhardt ND; Kouyos RD; Trkola A; Kusejko K; Bucher HC; Abela IA; Briel M; Speich B; ;
J Infect Dis; 2024 Jun; ():. PubMed ID: 38848312
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of immunological responses to third COVID-19 vaccine among people treated with sphingosine receptor-1 modulators and anti-CD20 therapy.
Sand IK; Gnjatic S; Krammer F; Tuballes K; Carreño JM; Satyanarayan S; Filomena S; Staker E; Tcheou J; Miller A; Fabian M; Safi N; Nichols J; Patel J; Krieger S; Tankou S; Horng S; Klineova S; Beck E; Merad M; Lublin F
medRxiv; 2022 Jun; ():. PubMed ID: 35734083
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of a bivalent BA.1 COVID-19 booster vaccine in people with HIV in the Netherlands.
Jongkees MJ; Tan NH; Geers D; de Vries RD; Geurtsvankessel CH; Hensley KS; Sablerolles RSG; Bogers S; Gommers L; Blakaj B; Afonso PM; Hansen BE; Rijnders BJA; Brinkman K; van der Kuy PHM; Roukens AHE; Rokx C
AIDS; 2024 May; ():. PubMed ID: 38788210
[TBL] [Abstract][Full Text] [Related]
19. Repeated mRNA vaccination sequentially boosts SARS-CoV-2-specific CD8
Ford ES; Mayer-Blackwell K; Jing L; Laing KJ; Sholukh AM; St Germain R; Bossard EL; Xie H; Pulliam TH; Jani S; Selke S; Burrow CJ; McClurkan CL; Wald A; Greninger AL; Holbrook MR; Eaton B; Eudy E; Murphy M; Postnikova E; Robins HS; Elyanow R; Gittelman RM; Ecsedi M; Wilcox E; Chapuis AG; Fiore-Gartland A; Koelle DM
Nat Immunol; 2024 Jan; 25(1):166-177. PubMed ID: 38057617
[TBL] [Abstract][Full Text] [Related]
20. Humoral response superiority of the monovalent XBB.1.5 over the bivalent BA.1 and BA.5 mRNA COVID-19 vaccines.
Lustig Y; Barda N; Weiss-Ottolenghi Y; Indenbaum V; Margalit I; Asraf K; Doolman R; Chalkias S; Das R; Elfatarany G; Harats D; Kreiss Y; Regev-Yochay G
Vaccine; 2024 May; ():. PubMed ID: 38806352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
